IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells. - Wikidata - awgldk - TriplyDB

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

http://www.wikidata.org/entity/Q34585798

about

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma Dendritic cell immunotherapy in uterine cancer.Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.Therapeutic vaccines for high-risk HPV-associated diseases.Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

P2860

Q27307719-D77D061F-2B17-4E8C-B773-4C6D54C184B7 Q28071998-6BE28CA9-7086-4880-AF7A-2F4D5B3DB3F9 Q34291122-766E7E19-9DF1-464E-8BB8-26CA22C99B2D Q34993170-6136BFE2-B003-4620-9660-A56AF0E1222D Q38208388-AB2E9781-57F2-43B1-9EEC-AED558E3EAB7 Q42415554-5F17B86C-0B7B-4ADF-A994-E3737764E9AE Q47255618-A363AC9B-BBE0-4B8A-92AF-A8885DD50834 Q51063063-C7DBF223-63D4-410A-AC11-1D6436BF761C Q55293126-5D8340A4-E955-4635-9300-82FCEBE92A76 Q55515909-102B4BEF-BAC2-4553-B9B4-FC9976449391

P2860

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

http://www.wikidata.org/entity/Q34585798

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@ast

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@en

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@nl

type

label

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@ast

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@en

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@nl

prefLabel

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@ast

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@en

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@nl

P1433

Q34585798-1651A62D-EF1B-46E8-B03B-D4C9619FA982

P1476

Q34585798-94E59538-52C8-4D2F-9236-835C575F09AE

P2093

Q34585798-07576210-3AC1-457C-944F-35276991A320

Q34585798-08BCD762-7F2A-4898-A705-7D8F8E762263

Q34585798-3F0B38A2-E552-4BCD-8302-72076BADFAC4

Q34585798-963C4749-07C4-403E-96C5-C0DF2144DB7F

Q34585798-B2132EDE-5E01-4ACB-9131-568A759547DE

Q34585798-B3A9164F-DCFC-4012-9C46-E2D95252C38A

P2860

Q34585798-0AB82625-D83C-45A0-9771-18B340B1F72D

Q34585798-0AC6D09C-67C9-45F6-BFDB-3471E1FB3AD9

Q34585798-0F23AC88-E8D7-455A-BE43-353DE936214E

Q34585798-119BF06D-DC89-4CCA-AE33-EE6ED40C6F2E

Q34585798-121871C2-B9CD-430A-AB3B-37714F46FC64

Q34585798-195B02A4-EBA1-4E8D-AFC3-00469D88036F

Q34585798-1A2E7993-4B53-49B0-A793-FBC59242ACF1

Q34585798-1C0457AB-20DF-4020-86A5-05F9A46C092A

Q34585798-1D29AC16-7315-468E-A85D-C37CA6546873

Q34585798-257C0D68-74FA-4B99-8B94-54E2C23DB451

P304

Q34585798-6A625862-2537-4D75-AAC9-7CCA52692CA5

P31

Q34585798-7771939B-577C-4301-B75E-AAF9D26B78CD

P356

Q34585798-AD2D3485-ED54-4B6D-A8A0-548F2A628033

P407

Q34585798-98ED57D0-3772-415F-928A-AB89FDA7247A

P433

Q34585798-6FE72CCC-6709-4B0D-B8FA-D3C95248C40C

P478

Q34585798-B8C9669B-64D6-402F-B631-8966A06653D6

P577

Q34585798-C59FCD57-52FA-4CE8-9FFC-DDE2055F4270

P5875

Q34585798-A33D52ED-F935-4330-AAFB-FEAD970543D5

P698

Q34585798-77513A30-3947-43BE-859D-467582287F47

P921

Q34585798-C2BE8A39-63C7-4C5D-9F4B-8B2FF19C4136

P932

Q34585798-28266C0F-BBC4-4926-8F51-E8CC3B0A48E8

P356

JOURNAL.PONE.0047234

P1433

P1476

IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.

@en

P2093

Bastian Schilling

http://www.w3.org/2001/XMLSchema#string

James Egan

http://www.w3.org/2001/XMLSchema#string

Malgorzata Harasymczuk

http://www.w3.org/2001/XMLSchema#string

Patrick Schuler

http://www.w3.org/2001/XMLSchema#string

Soldano Ferrone

http://www.w3.org/2001/XMLSchema#string

Theresa L Whiteside

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells and the control of immunity

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.

PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.

IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model.

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression.

Dendritic cells in a mature age.

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

Antigen processing and presentation: TAPping into ABC transporters.

P304

e47234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0047234

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235621935

http://www.w3.org/2001/XMLSchema#string

P698

23408925

http://www.w3.org/2001/XMLSchema#string

P921

P932

3567103

http://www.w3.org/2001/XMLSchema#string